A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer†. (2014)

First Author: McNeish IA
Attributed to:  Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdu363

PubMed Identifier: 25070546

Publication URI: http://europepmc.org/abstract/MED/25070546

Type: Journal Article/Review

Volume: 25

Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology

Issue: 10

ISSN: 0923-7534